GPT Healthcare Ltd

- GPT Healthcare Limited has achieved a significant milestone by becoming a net debt-free company as of FY '25. - There has been a sharp decline in finance cost by 55% Y-o-Y, driven by a strategic reduction in debt. - No specific mentions or indications of any current or upcoming fundraisings through debt or equity were disclosed during the call. - The company is focusing on growth via operational expansion (e.g., Raipur hospital and planned Jamshedpur hospital) funded through internal or existing resources. - Overall, the management emphasized financial strength and balance sheet improvement, suggesting no immediate plans for fundraising through debt or equity.

- Commissioned a 158-bed facility at Pachpedi Naka in Raipur on May 2, 2025, under an asset-light rental model, marking significant capital investment. - Signed an MoU for a new 150-bed hospital in Jamshedpur with an estimated investment of approximately INR 65 crores; expected commissioning by end of Q3 FY '27. - Plans to scale up to a 1,000-bed hospital chain over the next 2 to 3 years through such expansions. - Raipur hospital project cost was approximately INR 55 crores. - Ranchi project is delayed awaiting developer clearances; no capex details given yet. - Focus on introducing newer specialties and expanding super-specialty treatments across existing and new hospitals to drive growth.

- The company expects a 15% year-on-year (Y-o-Y) growth driven by new hospitals and introduction of newer specialties in existing hospitals. - Growth has been historically over 15% CAGR, though FY '25 saw largely flat volume growth due to external factors. - New hospital in Raipur expected to stabilize occupancies around 20% in the first year, breakeven at 35% occupancy within 24 months. - Jamshedpur hospital planned with 150 beds, expected commissioning by end of Q3 FY '27, contributing to future growth. - Focus on increasing Average Revenue Per Occupied Bed (ARPOB) by 8-12% annually across hospitals through specialty services and short-stay surgeries. - Occupancy rates targeted to improve in key hospitals for FY '26: Dum Dum ~72-73%, Salt Lake ~70%, Agartala ~55%, Howrah ~50%. - Oncology and other specialty expansions, including kidney transplant at Agartala, to enhance volumes.

- GPT Healthcare expects a 15% year-on-year growth driven by new hospitals and introduction of newer specialties across existing hospitals. - EBITDA margin guidance for the coming year is forecasted between 22.5% to 23%, despite a 5-6% EBITDA impact due to losses from the new Raipur hospital. - The Raipur facility aims to break even within 24 months, targeting around 35% occupancy. - ARPOB (Average Revenue Per Occupied Bed) growth is projected at 7-15% across various hospitals, with specialty services like oncology and cardiology being key growth drivers. - Cost inflation is expected to be around 7-8%, with focused efforts on cost control to maintain profitability. - The company aims to strengthen operations, expand bed capacity to 1,000 beds over 2-3 years, and improve returns with an ROE of 23.5% reported in FY ’25.

The transcript does not explicitly mention any details about the current or expected orderbook or pending orders for GPT Healthcare Limited. However, related expansion and project updates include: - Signed an MoU for a 150-bed hospital in Jamshedpur, with an estimated investment of ~INR 65 crores, expected commissioning by Q3 FY '27. - Ranchi project is delayed due to developer clearances; building constructed up to G+4, undergoing modifications. - Recently commissioned a 158-bed hospital at Pachpedi Naka, Raipur under an asset-light rental model. - Company aims to become a 1,000-bed hospital chain over the next 2-3 years. No specific orderbook or pending orders figures disclosed during the call.